Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19. (2021)
Attributed to:
Optimising therapeutic strategy in psoriasis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1001/jamanetworkopen.2021.29639
PubMed Identifier: 34661663
Publication URI: http://europepmc.org/abstract/MED/34661663
Type: Journal Article/Review
Volume: 4
Parent Publication: JAMA network open
Issue: 10
ISSN: 2574-3805